Why the jaw is not a
cosmetic problem

A patient came in wanting filler. She had been staring at photos of herself for months and decided the left side of her face was flatter. She wanted volume there to even things out.

I asked her to clench.

The right masseter locked down hard. The left side barely registered. I ran my fingers along both jaw angles. The right side was dense, prominent, the jaw angle sitting noticeably lower. Her chin tilted left.

She did not have a flat left side. She had an overgrown right side.

I turned her toward the mirror and showed her the tilt. She stared for a moment. Said she had never noticed it. Then said she had been grinding her teeth for as long as she could remember.

Most of my asymmetry patients have been grinding for a long time.

The muscle that builds your bone

Most patients know the masseter as a chewing muscle. It runs from the cheekbone down to the mandible, and it is one of the strongest muscles in the body relative to its size.

What gets less attention is that the masseter does not just move the jaw. Over time, it shapes it.

Bone responds to mechanical load. This is Wolff's Law. Bone grows where force is applied and thins where it is not. A jaw under years of chronic clenching responds by thickening. The cortical bone at the jaw angle remodels around the muscle. The mandible widens on the overworked side.

If one masseter is substantially stronger than the other, the bone on that side develops more. The jaw angle sits lower. The face pulls. The chin tilts toward the weaker side because the stronger side is carrying more weight.

So when patients come in saying one side looks bigger, they are usually right. The side that looks bigger often is bigger, structurally, all the way down to the bone.

What happens on the other side

When one masseter is dominant, the opposite side compensates. It works harder to keep the bite balanced, which means it gets a stronger signal to grow. You end up with one side enlarged from overuse and one side hypertrophying in response. Different reasons, same result.

When I inject the dominant side, it quiets. But the compensating side does not automatically follow. It is still working as if the dominant side is there.

This is why I never try to achieve symmetry in a single session.

I dose based on palpation while the patient clenches. Not a standard number: what I feel that day. The firmness, the volume, the way one side locks harder than the other. The compensating side often gets a lighter dose, or nothing at all in early sessions. The dominant side needs to reduce first before I start asking the other side to change.

If you get the sequence wrong, you push the asymmetry the other way. You end up chasing the muscle.

The bone question

Patients find this online and it is usually presented in a way that sounds alarming, so I want to address it plainly.

Masseter Botox does change bone.

Research shows roughly a six percent reduction in cortical bone thickness in the mandibular region with repeated injections. The mandible as a whole does not shrink. The outer shell thins in response to reduced muscle load.

The aesthetic literature calls this an adverse effect. I understand that framing. But it only makes sense if you assume the bone was normal to begin with.

If a masseter has been overworked for decades, from bruxism, from genetics, from a bite that loads one side harder than the other, the bone underneath is not at baseline. It is thickened from abnormal force. What I think gradual Botox treatment does is reduce that force slowly enough for the bone to move back toward what it would have been. Not smaller than it should be. Closer to what it was before years of excessive load shaped it.

This is my clinical reasoning. There is no long-term randomized trial tracking masseter Botox patients over a decade and comparing bone outcomes in hypertrophied versus normal mandibles. I am working from Wolff's Law, from bone remodeling biology, and from what I see in my patients over time. That is not the same as settled evidence.

I came to this way of thinking through Dr. Woffles Wu, a craniofacial surgeon in Singapore who has spent decades teaching facial sculpting with neuromodulators. He looks at the face as a structural system. That changed how I work.

The temples

Something patients do not expect: when the masseter reduces, the temporal area often gets fuller. And this is not just a proportional illusion. There is actual measurable volume change.

When the masseter is weakened, the temporalis compensates. It works harder to maintain chewing function, and that increased activity causes it to increase in volume and thickness. Studies have confirmed this using ultrasound and 3D scanning.

I had a patient come in this year specifically about her temples. She had researched her options, knew what filler she wanted, and was ready to book. When I examined her, the temporal volume was fine. Her lower face was just wide enough that everything above it read as hollow by comparison.

We treated her masseters.

Three months later the temples looked fuller. The lower face had narrowed, the temporalis had picked up activity, and the proportions shifted without adding anything. She did not need filler. She needed a different question asked first.

Before I add anything to the temples, I want to understand the jaw. That is not always the answer, but it is always worth asking.

How I dose

Every session is different.

I palpate while the patient clenches, feeling for volume, firmness, the difference between sides. Some patients have a masseter visibly larger on one side. Others feel balanced at rest and then one side locks hard under load. That is what shapes the dose.

As the muscle atrophies over time, the dose comes down. A smaller, quieter muscle does not need the same signal. Intervals extend. I am looking for the floor: the lowest dose and the longest interval that holds the result.

There is an endpoint. When both sides have reached a similar size and had time to remodel, roughly two years of consistent treatment in my experience, I move patients to maintenance. Less frequent, smaller doses.

And there is a stop condition. When I start seeing early laxity in the jawline, when the skin is losing the structural support the muscle was providing, I pull back. The masseter holds up the lower face. I would rather catch that early than explain it after the fact.

Perimenopause

I do not have a hard rule against treating perimenopausal patients. But I start this conversation early, sometimes at the very first session, years before it matters, so it is never a surprise when it does.

After menopause, the masseter does not grow back as aggressively. Estrogen supports both muscle and bone metabolism, and when it declines, the dynamic changes. Results last longer, which sounds good. But it also means the margin is narrower. You cannot rely on full muscle recovery between sessions to buffer the jaw structure.

Estrogen also plays a direct role in bone density throughout the skeleton, including the mandible. When it declines, resorption risk goes up. I am not aware of a clinical trial specifically on masseter Botox and perimenopausal bone loss. That gap in the evidence is real, and I say so. What I have is a mechanistic reason for caution that I take seriously enough to change how I practice.

For perimenopausal patients I use smaller doses, observe longer between sessions, and focus treatment on whichever side actually needs it rather than treating both equally. For patients on HRT the picture shifts. Estrogen support matters, and we can often work with a more standard approach. But I monitor more closely regardless.

I am not willing to risk bone health for aesthetics. That is where I hold the line.

What people find online

Jowling. Hollowing. A face that aged from treatment. These outcomes are real.

In most cases I have looked at, the pattern is the same: too much reduction, too fast, in someone who was not carefully assessed beforehand. When the masseter reduces faster than the overlying skin can adapt, the jawline loses support. In patients with pre-existing laxity, or older patients, or patients with naturally thinner soft tissue, the skin does not tighten. It drops.

The people describing these experiences are not wrong. What is usually missing from the account is what led there: the dose, the pacing, whether anyone was watching between sessions.

I see patients between appointments, not just when the Botox wears off. I want to see what the face is doing in the middle, not just at the end of a cycle.

The injection takes a few minutes. The work is the two years of watching.